CN Stock MarketDetailed Quotes

688443 Chongqing Genrix Biopharmaceutical

Watchlist
  • 37.27
  • -0.41-1.09%
Market Closed May 31 15:00 CST
13.67BMarket Cap-17883P/E (TTM)

Chongqing Genrix Biopharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Chongqing Genrix Biopharmaceutical Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 30, 2024

Revenue(YoY)

6.33K

-93.67%
EPS(YoY)

-0.45

+38.36%
Analyst Rating

Strong Buy

May 31, 2024

Chongqing Genrix Biopharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 340.750M--
--2024/FY-- / 107.250M--
--2023/FY1.212M / 50.000K--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 340.750M--
--2024/FY-- / 107.250M--
--2023/FY1.212M / 50.000K--

Chongqing Genrix Biopharmaceutical Earnings Reports

  • 2024 First Quarter Report

    Apr 29 12:00 ET

  • 2023 Annual Report Summary

    Apr 29 12:00 ET

  • 2023 Annual Report

    Apr 29 12:00 ET

  • Chongqing Zhixiang Jintai Biopharmaceutical Co., Ltd. 2023 Annual Performance Report

    Feb 23 11:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 31, 2024

    Strong Buy

    • Strong Buy

      75.00%

    • Buy

      25.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg